Capture Consent: How to Protect Your Business and Your Clients

  • |
  • 01 mins 05 secs
Protecting your business is a priority. Fraudulent account opening activity could lead to reputation risk and significant fines from regulatory agencies. The good news is you can capture consent without sacrificing your customer experience.

DocuSign’s experience in financial services can help you get a jump start on capture consent compliance without creating more work for your customers. This is an opportunity to optimize your process and delight your customers, and DocuSign can help.

Please click here to view the white paper.

Channel

DocuSign
Image Map
About DocuSign Since inception in 2003, DocuSign has been on a mission to accelerate business and simplify life for companies and people around the world. We pioneered the development of e-signature technology, and today offer the world’s #1 e-signature solution. It’s just part of our broader cloud-based System of Agreement Platform, which allows companies of all sizes and across all industries to quickly modernize and digitize the entire agreement process—all the way from preparing agreements to signing, enacting and managing them—from almost anywhere in the world, on practically any device. Our value is simple to understand: Legacy, paper-based agreement processes are manual, slow, expensive, and error-prone. We eliminate the paper, automate the process, and connect it to all the other systems that businesses are already using. Our platform has 350+ prebuilt integrations with popular business apps. In addition, our API enables embedding and connecting DocuSign with customers’ websites, mobile apps, and custom workflows. All told, today this enables more than 400,000 customers and hundreds of millions of users to measure turnaround time in minutes rather than in days, substantially reduce costs, and largely eliminate errors. Fast facts More than 400,000 paying customers and hundreds of millions of users worldwide. Seven of the top 10 global technology companies. Eighteen of the top 20 global pharmaceutical companies. Ten of the top 15 global financial services companies.